PRECODOM: Evaluation of Early Home Return in Patients With Enucleation of Prostate Adenoma
Study Details
Study Description
Brief Summary
Prostate adenoma management includes, if necessary, surgical treatments: resection or vaporization by endoscopy or by open surgery in case of a very large prostate. Laser technology is a curative treatment for prostate adenoma. The minimum duration of hospitalization, in the context of enucleation prostatic endoscopy by laser, is estimated at 48 hours.
The Union Clinique has developed an improved rehabilitation care pathway reducing hospitalization duration to 24 hours (one night hospitalization). This care pathway involves patient as an actor in its care but also health professionals, in particular nurses.
This study is based on the hypothesis that the model developed by the Union Clinique can be translated to other healthcare establishments and that home return supervized by nurses allows reducing hospital stay length without increasing the risk of serious complications for patients
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Detailed Description
Prostate adenoma management includes first drug treatments and, if necessary, surgical treatments: resection or vaporization by endoscopy or by open surgery in case of a very large prostate. Laser technology is a curative treatment for prostate adenoma. Its objective is to perform endoscopic excision (ablation) of the adenoma, in order to improve patients' quality of life and their urination. The laser energy is transmitted by a guided fiber under endoscopic control through the urethral canal in contact with the adenoma. Several wavelengths of the laser beam, depending on the nature of the generator crystals, are used for their specificity in cutting and tissue cauterization: Greenlight laser, Holmium laser, Thulium laser.
The minimum duration of hospitalization, in the context of an enucleation prostatic endoscopy by laser, is estimated at 48 hours. The Union Clinique has developed an improved rehabilitation care pathway reducing hospitalization duration to 24 hours (one night hospitalization). This care pathway involves patient as an actor in its care but also health professionals, in particular nurses, who will coordinate patients care prior to their intervention and when they leave the Clinics.
This study is based on the hypothesis that the model developed by the Union Clinique can be translated to other healthcare establishments and that home return supervized by health professionals, notably nurses, allows reducing hospital stay length without increasing the risk of serious complications for patients
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: Early home return arm Nurses will coordinate the patients' care prior to their intervention and when they leave the Clinics. |
Other: Patient support
Patients will be supported by nurses before and after intervention and hospital leave
|
No Intervention: Standard Of Care arm Patients will not receive any support before and after intervention and hospital leave |
Outcome Measures
Primary Outcome Measures
- Re-hospitalizations and/or hospitalization extensions rate [2 weeks]
the percentage of re-hospitalizations and/or hospitalization extensions
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Patient planned for endoscopic enucleation of prostate adenoma with laser
-
Patient with symptomatic benign prostatic hyperplasia and refractory to medical reatment and/or
-
Patient with benign prostatic hyperplasia complicated by chronic retention of urine and/or
-
Patient with benign prostatic hyperplasia complicated by prostatitis and/or
-
Patient with symptomatic benign prostatic hyperplasia
Exclusion Criteria:
-
Patient living beyond the scope of care by the nurses coordination
-
Bedridden patient or WHO clinical condition >2
-
Patient requiring curative anticoagulation which cannot be interrupted or relayed at home by heparin
-
Patient with double anti-platelet aggregation who cannot be interrupted
Contacts and Locations
Locations
No locations specified.Sponsors and Collaborators
- GCS Ramsay Santé pour l'Enseignement et la Recherche
Investigators
- Principal Investigator: Philippe ROUVELLAT, MD, GCS RAMSAY SANTE
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 2023-A00283-42